MMJ is currently engaged in litigation with the Drug Enforcement Administration (DEA). The company contends that the DEA has ...

The Madison Re-Prom is returning to the Monona Terrace this February for its 13th year. The annual gala brings grown ups back ...

Symptoms of Huntington's disease appear late in life. Research reveals how DNA repeats grow toxic over time, explaining the ...

Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...

New genetic research shows why some people develop deadly Huntington's disease earlier than others. The findings could lead to better treatments.

Huntington's disease is a hereditary disorder caused by a genetic mutation in the HTT gene, leading to progressive brain cell damage, affecting movement, cognition, and behavior, with no current cure.

Log-rolling champ Shana Verstegen's event to raise funds for Huntington's disease research will once again take place at the Monona Terrace on Feb. 15.

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...

Reports Q4 revenue $627.7M, consensus $629.44M. “I’m proud of the tremendous progress we made last year with the continued growth of INGREZZA ...